← Back to Search

PARTNER Intervention for HIV Prevention (PARTNER Trial)

N/A

Waitlist Available

Led By Tyrel J Starks, PhD

Research Sponsored by Hunter College of City University of New York

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 to 29 years of age (inclusive)

Must be in a main partner relationship with another male (duration ≥ 1 months)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 month

Awards & highlights

PARTNER Trial Summary

This trial looks at whether a 4-session motivational intervention can help YMSM in relationships to take PrEP, reduce HIV transmission risk behavior, and associated drug use.

Who is the study for?

This trial is for young men who have sex with men (YMSM), aged 18-29, living in the NYC area. They must be HIV-negative, speak English, and be in a relationship for at least a month. Candidates should meet CDC criteria for PrEP use due to recent risky sexual behavior or substance use.Check my eligibility

What is being tested?

The PARTNER intervention is being tested; it's a short program using motivational interviewing over four sessions aimed at increasing uptake and adherence to PrEP, reducing HIV risk behaviors and drug use among YMSM.See study design

What are the potential side effects?

Since this trial focuses on education and behavioral interventions rather than medication, there are no direct medical side effects. However, participants may experience emotional discomfort discussing personal topics.

PARTNER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 29 years old.

Select...

I have been in a relationship with another man for at least 1 month.

Select...

I have used substances like marijuana, cocaine, or MDMA in the last 30 days.

PARTNER Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of HIV transmission risk events

Number of drug use instances

Positive drug assays

+2 more

Secondary outcome measures

Effectiveness of intervention implementation

Pre-Exposure Prophylaxis (PrEP) adherence

PARTNER Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PARTNER InterventionExperimental Treatment1 Intervention

This intervention is a four-session intervention designed to increase PrEP uptake, increase PrEP adherence, and reduce drug use and HIV transmission risk behaviors of individuals in relationships.

Group II: Education InterventionActive Control1 Intervention

This intervention is a four-session intervention that discussed drug use and its effect on physiological social functioning.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PARTNER

2018

N/A

~200

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Hunter College of City University of New YorkLead Sponsor

38 Previous Clinical Trials

8,686 Total Patients Enrolled

6 Trials studying Substance Use

1,446 Patients Enrolled for Substance Use

National Institute on Drug Abuse (NIDA)NIH

2,481 Previous Clinical Trials

2,620,617 Total Patients Enrolled

68 Trials studying Substance Use

37,752 Patients Enrolled for Substance Use

Tyrel J Starks, PhDPrincipal InvestigatorHunter College of City University of New York

4 Previous Clinical Trials

500 Total Patients Enrolled

1 Trials studying Substance Use

86 Patients Enrolled for Substance Use

Media Library

Substance Use Research Study Groups: PARTNER Intervention, Education Intervention

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any spots open to participate in this research experiment?

"Affirmative. Clinicaltrials.gov displays information that this research is actively seeking participants; the original posting was made on February 14th 2018, and it has since been refreshed November 13th 2020. The recruitment goal for this experiment calls for 240 individuals from a singular site."

Answered by AI

Do I fulfill the standards to participate in this trial?

"This clinical trial is recruiting two hundred and forty young adults between 18 to 29 years of age that are considered at risk for HIV. Qualified participants must be in an established relationship with a partner over the age of eighteen, have used one or more substances from the most commonly consumed list (e.g marijuana, cocaine etc.) within thirty days prior to recruitment, reside in the New york City Metro area and possess basic English proficiency skills. Additionally they must hold an HIV-negative status confirmed by rapid test results as well as meet sexual behavior criteria set forth by The Centre For Disease Control's Prep candidacy requirements."

Answered by AI

Does the trial accept participants who are in their twilight years?

"The requirements for joining this clinical trial state that the patient must be between 18 to 29 years old. Furthermore, there are 139 studies available for participants aged under 18 and 468 trials intended for those over 65."

Answered by AI

What is the enrollment rate for this clinical trial?

"Affirmative; according to clinicaltrials.gov, this medical trial has been open since February 14th 2018 and is still enrolling participants as of November 13th 2020. The researchers are targeting 240 volunteers from 1 site."

Answered by AI

Recent research and studies

Journal of Consulting and Clinical PsychologyJournal

A Randomized Controlled Trial Utilizing Motivational Interviewing to Reduce HIV Risk and Drug Use in Young Gay and Bisexual Men.

Parsons, Jeffrey T., Corina Lelutiu-Weinberger, Michael Botsko, and Sarit A. Golub. 2014. “A Randomized Controlled Trial Utilizing Motivational Interviewing to Reduce HIV Risk and Drug Use in Young Gay and Bisexual Men.”. Journal of Consulting and Clinical Psychology. American Psychological Association (APA). doi:10.1037/a0035311.

JMIR Research ProtocolsJournal

Motivational Interviewing to Reduce Drug Use and HIV Incidence Among Young Men Who Have Sex with Men in Relationships and Are High Priority for Pre-exposure Prophylaxis (project PARTNER): Randomized Controlled Trial Protocol

Starks, Tyrel J, Gabriel Robles, Mark Pawson, Ruben H Jimenez, Monica Gandhi, Jeffrey T Parsons, and Brett M Millar. 2019. “Motivational Interviewing to Reduce Drug Use and HIV Incidence Among Young Men Who Have Sex with Men in Relationships and Are High Priority for Pre-exposure Prophylaxis (project PARTNER): Randomized Controlled Trial Protocol”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/13015.

clinicaltrials.govStudy

Prevention and Risk: Treatment With a New Emphasis on Relationships

Tyrel Starks 2018. "Prevention and Risk: Treatment With a New Emphasis on Relationships". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03396367.